We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dialysis Enhances Oxidative Stress

By HospiMedica staff writers
Posted on 28 Apr 2005
Many dialysis patients are in a state of chronic inflammation induced by the dialysis process, which further enhances oxidative stress, a state associated with long-term complications such as cardiovascular disease, malnutrition, poor outcome, and low survival, according to a new study.

Oxidative stress (OS) is the result of an imbalance between toxic compounds and defense mechanisms. More...
Prevalent in the dialysis process, it has been linked to numerous adverse complications in end-stage renal disease patients. The imbalance is caused by the overproduction of reactive oxygen species (ROS), or toxic compounds, and the lack of antioxidants to fight these toxins. The hemodialysis process can cause loss of these necessary antitoxins.

"It is important to prevent reactive oxygen species production by improving the biocompatibility of the hemodialysis system,” observed Dr. Jean-Paul Cristol, M.D., corresponding author of the study and head of the biochemistry department at Lapeyronie University Hospital (Montpellier, France). The study was published in the March 30, 2005, issue of Hemodialysis International.

Antioxidant supplement and ROS modulation by specific or nonspecific drugs, such as statins, are possible solutions outlined in the article. "Correction of OS imbalance appears to be a basic requisite to prevent complications in long-term dialysis patients” and is "a promising avenue of research,” said the authors.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.